Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8978 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8978 |
High Similarity |
NPD1613 |
Approved |
0.8897 |
High Similarity |
NPD3027 |
Phase 3 |
0.8686 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8613 |
High Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8523 |
High Similarity |
NPD1653 |
Approved |
0.8345 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.8261 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8199 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8175 |
Intermediate Similarity |
NPD1091 |
Approved |
0.8156 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8153 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8148 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8137 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8137 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8108 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.8098 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8065 |
Intermediate Similarity |
NPD37 |
Approved |
0.8049 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8043 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.8042 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8025 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8025 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8025 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7975 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7949 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7937 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7911 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7898 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7892 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7892 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7847 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7832 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7831 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7791 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7786 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7754 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.773 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7712 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7676 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7676 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7676 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7673 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7671 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7632 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7606 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7586 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7571 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7562 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7545 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7536 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7533 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7533 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7533 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7518 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD228 |
Approved |
0.7456 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7455 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7453 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.745 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.745 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.745 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7445 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7436 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7436 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7423 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7412 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7407 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7407 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7405 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7403 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7375 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.7368 |
Intermediate Similarity |
NPD4108 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7362 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7353 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7353 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7346 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7346 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7342 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7333 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7317 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7315 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7301 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7285 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7285 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD1375 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7273 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7267 |
Intermediate Similarity |
NPD4678 |
Approved |
0.726 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7257 |
Intermediate Similarity |
NPD6842 |
Approved |
0.7257 |
Intermediate Similarity |
NPD6841 |
Approved |
0.7257 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.7248 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7246 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7244 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7241 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7215 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7213 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7205 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7205 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.719 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7184 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7172 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7171 |
Intermediate Similarity |
NPD5735 |
Approved |
0.717 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7163 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7162 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7162 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7153 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7134 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7134 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7125 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7115 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7105 |
Intermediate Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7097 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7091 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7091 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7089 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7086 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.708 |
Intermediate Similarity |
NPD290 |
Approved |
0.7073 |
Intermediate Similarity |
NPD3382 |
Approved |
0.7073 |
Intermediate Similarity |
NPD3383 |
Approved |
0.7073 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7073 |
Intermediate Similarity |
NPD3384 |
Approved |
0.707 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.707 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7069 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7063 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7059 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7051 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7051 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7051 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7029 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7029 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7025 |
Intermediate Similarity |
NPD4535 |
Phase 3 |
0.7025 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7025 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7025 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7025 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7013 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7012 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7007 |
Intermediate Similarity |
NPD968 |
Approved |
0.6993 |
Remote Similarity |
NPD4140 |
Approved |
0.6993 |
Remote Similarity |
NPD2238 |
Phase 2 |
0.6989 |
Remote Similarity |
NPD8053 |
Approved |
0.6989 |
Remote Similarity |
NPD8054 |
Approved |
0.6987 |
Remote Similarity |
NPD3539 |
Phase 1 |
0.6975 |
Remote Similarity |
NPD5403 |
Approved |
0.6968 |
Remote Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.6962 |
Remote Similarity |
NPD4162 |
Approved |
0.6962 |
Remote Similarity |
NPD4237 |
Approved |
0.6962 |
Remote Similarity |
NPD4236 |
Phase 3 |
0.6959 |
Remote Similarity |
NPD6583 |
Phase 3 |
0.6959 |
Remote Similarity |
NPD3685 |
Discontinued |
0.6959 |
Remote Similarity |
NPD6582 |
Phase 2 |
0.6959 |
Remote Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.6957 |
Remote Similarity |
NPD4123 |
Phase 3 |
0.695 |
Remote Similarity |
NPD5535 |
Approved |
0.6948 |
Remote Similarity |
NPD4340 |
Discontinued |
0.6946 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6944 |
Remote Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.6937 |
Remote Similarity |
NPD7124 |
Phase 2 |
0.6933 |
Remote Similarity |
NPD3687 |
Approved |
0.6933 |
Remote Similarity |
NPD3686 |
Approved |
0.6927 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6914 |
Remote Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.6909 |
Remote Similarity |
NPD7411 |
Suspended |
0.6899 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6894 |
Remote Similarity |
NPD4357 |
Discontinued |
0.6894
|
Remote Similarity |
NPD6799 |
Approved |